Christopher Causey
Director at UNITED THERAPEUTICS Corp (UTHR)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 31SEC | UTHRUNITED THERAPEUTICS Corp | Sell Plan | 1,3004,190 held (−24%) | $604.64 | $786K | -9.2% |
| Mar 5SEC | UTHRUNITED THERAPEUTICS Corp | Sell Plan | 204,190 held (−0%) | $490.17 | $10K | +12.0% |
| Feb 25SEC | UTHRUNITED THERAPEUTICS Corp | Sell Plan | 1,0004,190 held (−19%) | $520.00 | $520K | +5.6% |
| Jan 6SEC | UTHRUNITED THERAPEUTICS Corp | Sell Plan | 1,0004,190 held (−19%) | $510.00 | $510K | +7.7% |
| Jan 5SEC | UTHRUNITED THERAPEUTICS Corp | Sell Plan | 1,0004,190 held (−19%) | $500.01 | $500K | +9.8% |
- Sell
Director Christopher Causey sold $786K of UTHR at $604.64 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Causey sold $10K of UTHR at $490.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Causey sold $520K of UTHR at $520.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Causey sold $510K of UTHR at $510.00 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Christopher Causey sold $500K of UTHR at $500.01 — pre-scheduled 10b5-1 plan sale.